Gilead Sciences' net income 2006-2019

Gilead Sciences' net income amounted to nearly 5.4 billion U.S. dollars in 2019. The statistic illustrates Gilead Sciences' net income from 2006 to 2019. The company shot to the public spotlight in the first quarter of 2020 for its drug remdesivir, which was trialed against COVID-19.

Gilead Sciences' net income from 2006 to 2019

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2020

Region

Worldwide

Survey time period

2006 to 2019

Supplementary notes

Figures for 2006-2013 were quoted from previous annual reports.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.